IMMP
IMMUTEP Ltd
$0.42
-0.01 (-2.33%)
At close · Jul 2
Market Cap
$62.10M
Shares
1,460,389,575
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.42
Open$0.43
Day$0.41–0.44
52W$0.29–3.53
Avg vol 30d697K
Short int4.4M · 0.3% float · 5.9d
Short vol22%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−74% below
◦
Price vs 50-day avg
−3% below
◦
RSI (14)
52 · neutral
+
MACD trend
positive
−
52-week position
4% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $0 › 200d $2 — 200d above 50d
+
Institutional flow
+8% holders QoQ · +11 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.30% of float · ▲ +2.2% MoM · 5.9 days cover
◦
Volume signal
High volume on a down day — possible exhaustion
◦
Institution breadth
28 holders — mid 3-yr range
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−74% below
Bearish
Price vs 50-day avg
−3% below
Neutral
RSI (14)
52 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
4% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.30% of float · ▲ +2.2% MoM · 5.9 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
28 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 4%
52-wk high $4
vs 200-day avg -74%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMMP
this stock
IMMUTEP Ltd
|
$62.10M | -85.3% | — | — | 0.3% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMMP | +2.4% | +2.4% | -85.9% | +0.0% | -85.3% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +1.0% | +3.7% | -93.9% | +0.3% | -94.5% |